OpGen subsidiary gets €750k advance payment; in talks for strategic transaction

CapForce Inc.

Curetis GmbH received €750k advance payment from a strategic partner for Unyvero A50 systems.
Payment relates to potential strategic transaction involving Curetis and Ares Genetics.
Strategic partner may buy additional Unyvero A50 systems during ongoing negotiations.
Proceeds to fund Curetis and Ares Genetics operations while deal discussions continue.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.